180 related articles for article (PubMed ID: 12684913)
1. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?
Paterson DL; Rice LB
Clin Infect Dis; 2003 Apr; 36(8):1006-12. PubMed ID: 12684913
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.
Malacarne P; Rossi C; Bertolini G;
J Antimicrob Chemother; 2004 Jul; 54(1):221-4. PubMed ID: 15190030
[TBL] [Abstract][Full Text] [Related]
4. Efforts of pharmacy to reduce antibiotic resistance.
Klem C; Dasta JF
New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
[TBL] [Abstract][Full Text] [Related]
5. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.
Kuti JL; Shore E; Palter M; Nicolau DP
Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192
[TBL] [Abstract][Full Text] [Related]
6. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
[TBL] [Abstract][Full Text] [Related]
7. Appropriate use of antimicrobial agents: challenges and strategies for improvement.
Niederman MS
Crit Care Med; 2003 Feb; 31(2):608-16. PubMed ID: 12576973
[TBL] [Abstract][Full Text] [Related]
8. [Strategies targeted at optimising antimicrobial therapy in critically ill patients].
Eggimann P; Oddo M; Voirol P; Zanetti G; Chioléro R
Rev Med Suisse; 2005 Dec; 1(45):2928-32. PubMed ID: 16425950
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic prescribing pattern in a medical intensive care unit in Qatar.
Hanssens Y; Ismaeil BB; Kamha AA; Elshafie SS; Adheir FS; Saleh TM; Deleu D
Saudi Med J; 2005 Aug; 26(8):1269-76. PubMed ID: 16127527
[TBL] [Abstract][Full Text] [Related]
10. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
Kollef MH
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
[TBL] [Abstract][Full Text] [Related]
11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
12. [Strategies in the treatment of infections with antibiotics in intensive care medicine].
Deja M; Nachtigall I; Halle E; Kastrup M; Guill MM; Spies CD
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):108-15. PubMed ID: 17309018
[TBL] [Abstract][Full Text] [Related]
13. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.
Erlandsson M; Burman LG; Cars O; Gill H; Nilsson LE; Walther SM; Hanberger H;
Scand J Infect Dis; 2007; 39(1):63-9. PubMed ID: 17366015
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic-resistant infections in the critically ill adult.
Silveira F; Fujitani S; Paterson DL
Clin Lab Med; 2004 Jun; 24(2):329-41. PubMed ID: 15177843
[TBL] [Abstract][Full Text] [Related]
15. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
16. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
17. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
18. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.
Mettler J; Simcock M; Sendi P; Widmer AF; Bingisser R; Battegay M; Fluckiger U; Bassetti S
BMC Infect Dis; 2007 Mar; 7():21. PubMed ID: 17386104
[TBL] [Abstract][Full Text] [Related]
19. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
Roberts JA; Webb SA; Lipman J
Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033
[TBL] [Abstract][Full Text] [Related]
20. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data.
Deresinski S
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S177-83. PubMed ID: 17712744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
